Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy
Bone Marrow Transplant. 2022 May;57(5):851.
doi: 10.1038/s41409-022-01629-2.
1 Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, INSERM CIC 1416, Assistance Publique-Hôpitaux de Paris, Paris, France. [email protected].
2 Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France. [email protected].
3 Paris Descartes University-Sorbonne Paris Cité, Imagine Institute, Paris, France. [email protected].
4 Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, INSERM CIC 1416, Assistance Publique-Hôpitaux de Paris, Paris, France.
5 Department of Biotherapy, Assistance Publique-Hôpitaux de Paris, Necker Children's Hospital, Paris, France.
6 Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
7 Paris Descartes University-Sorbonne Paris Cité, Imagine Institute, Paris, France.